Pick of the day: What Scott Gottlieb's exit from USFDA means for the Indian pharma sector

Scott Gottlieb, the chief of the US Food & Drug Administration, announced he will be stepping down next month. This has raised eyebrows among India’s drug makers on who will replace him and whether there will be continuity in some of the policies implemented by him. Gottlieb, who has led the FDA for nearly two years, is said to be leaving on account of personal commitments.